SCHEMBL12706329

SCHEMBL12706329

CSC1CC(=O)N(c2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)C1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 3/20 0.58
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ MEN1 O00255 2/20 0.49
▸ POLB P06746 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ ALPL P05186 1/20 0.49
▸ ALPI P09923 1/20 0.49
▸ ALPG P10696 1/20 0.49
▸ ATM Q13315 1/20 0.47
▸ PLEC Q15149 1/20 0.47
▸ CA9 Q16790 12/20 0.47
▸ CA1 P00915 10/20 0.47
▸ CA2 P00918 10/20 0.47
▸ CA12 O43570 4/20 0.45
▸ DNASE1L3 Q13609 1/20 0.45
▸ PRMT1 Q99873 1/20 0.45
▸ CA14 Q9ULX7 3/20 0.44
▸ ADRA1D P25100 1/20 0.43
▸ ADRA1A P35348 1/20 0.43
▸ ADRA1B P35368 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14586590 0.91 USP2 (0.55) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL12134945 0.89 USP2 (0.60) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL20276070 0.87 USP2 (0.58) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL22651493 0.84 USP2 (0.68) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL15057677 0.81 USP2 (0.48) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL14415288 0.81 FOLH1 (0.49) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL1103795 0.81 USP2 (0.69) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL15058042 0.80 FOLH1 (0.44) USP2L3MBTL1CA9CA1CA2
SCHEMBL16283416 0.80 USP2 (0.67) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL22702332 0.79 USP2 (0.72) USP2L3MBTL1MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765920-B2 Tyrosine bioconjugation through aqueous Ene-like reactions THE SCRIPPS RESEARCH INSTITUTE (US) 2014-07-01 — — US disclosed
US-20120289682-A1 Tyrosine Bioconjugation through Aqueous Ene-Like Reactions THE SCRIPPS RESEARCH INSTITUTE 2012-11-15 — — US disclosed
US-7919455-B2 Marked peptides having affinity for a phospholipid and uses COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2011-04-05 — — US disclosed
US-7851440-B2 Peptides with affinity for a phospholipid and uses COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2010-12-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120289682-A1 Tyrosine Bioconjugation through Aqueous Ene-Like Reactions TYR, DNPEP, TH USP2 875/4885L3MBTL1 2707/4885MEN1 3134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback